Mauritius-based entity sells Rs 289 crore worth shares in Emcure Pharmaceuticals via block deal; Norges Bank acquirer
Emcure Pharmaceuticals witnessed a block deal on Wednesday in which a Mauritius-based investment entity BC Investments IV Limited sold 18 lakh shares in a transaction that was valued at Rs 289 crore. The shares were purchased by Norges Bank on Account of The Government Pension Fund Global at a price of Rs 1,608.2 apiece. The…